Inactive Instrument

News LOCT WALK Nasdaq

Equities

LWACU

US54015L3015

Summary

Unlock all the news: Be the first to know and act before the market!

EFFECTOR Therapeutics : Accelaration/Increase of Financial Obligation Form 8 K	06-26	PU
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	06-24	MT
Top Midday Decliners	06-24	MT
Sector Update: Health Care Stocks Advance Monday Afternoon	06-24	MT
EFFECTOR Therapeutics to Shut Down Operations, Seeking Strategic Alternatives	06-24	MT
EFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq	06-24	AQ
EFFECTOR Therapeutics, Inc Appoints Craig R. Jalbert as CEO	06-24	CI
EFFECTOR Therapeutics, Inc. Appoints Craig R. Jalbert as President, Treasurer and Secretary, and Sole Member of the Board	06-24	CI
EFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer	05-20	CI
EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Health Care Down on Retreat From Risk -- Health Care Roundup	04-04	DJ
Top Midday Decliners	04-04	MT
EFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer	04-04	AQ
EFFECTOR Therapeutics, Inc. Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer	04-04	CI
Top Premarket Decliners	03-26	MT
EFFECTOR Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-25	CI
Transcript : EFFECTOR Therapeutics, Inc. - Special Call	03-15
EFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	02-05	AQ
EFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	01-25	AQ
Transcript : EFFECTOR Therapeutics, Inc. - Special Call	01-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News LOCT WALK Nasdaq

Equities

LWACU

US54015L3015

Summary

Filters